SEKISUI to Provide Metrix COVID/Flu Test to the POC and Home Test Markets
SEKISUI Diagnostics has launched the Metrix COVID/Flu Test, a rapid molecular diagnostic for SARS-CoV-2 and influenza.
Read More
Search Results for: point-of-care testing
With Few Diagnostic Tools and Treatments Mpox Could Become a Serious Global Threat
Mpox is evolving into a significant global health threat due in part to limited diagnostic tools and treatments.
Read More
COVID Next: Charting an Evolving Industry
Industry experts predict clinical diagnostics will continue evolving in the wake of COVID with automation, AI, and decentralized testing.
Read More
The COVID-19 Pandemic: Five Years On
The COVID-19 pandemic has reshaped healthcare, diagnostics, and public health preparedness, leaving lasting impacts on the industry.
Read More
Lipoprotein Profiling May Be Diagnostic Key for Heart Disease Risk
Researchers have successfully adapted high-field NMR-based lipoprotein analysis to cost-effective benchtop NMR systems.
Read More